Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma TrialLucas Moreno, Rebekah Weston, Cormac Owens et al.|Journal of Clinical Oncology|2024Cited by 25
Essential medicines for childhood cancer in Europe: a pan-European, systematic analysis by SIOPEMaria Otth, Elena Oltenau, Olga Kozhaeva et al.|The Lancet Oncology|2022Cited by 10